97Ru-transferrin uptake in tumor and abscess

P. Som, Z. H. Oster, K. Matsui, G. Guglielmi, B. R.R. Persson, M. L. Pellettieri, S. C. Srivastava, P. Richards, H. L. Atkins, A. B. Brill

Research output: Contribution to journalArticlepeer-review

Abstract

The uptake of97Ru-transferrin (Ru-TF) in tumor and abscess bearing animals was compared with67Ga-citrate (Ga),123I-transferrin (I-TF), and several other plasma proteins. Maximal concentration in tumor of Ru-TF in mice was three times higher than67Ga-citrate (16.80±4.20 vs 5.08±0.58% D/g) although it occurred later (24 h compared with67Ga which reached its maximum 2 h after injection). Whole body autoradiography (WBARG) with103Ru-transferrin (103Ru-TF) in tumor and abscess bearing rats demonstrated details of the distribution within these lesions. Turpentine-induced abscesses in the rabbits could be visualized with the gamma camera as early as 30 min post-injection of Ru-TF. It seems, therefore, that Ru-TF can be used for tumor and abscess localization. The results indicate that Ru-TF may have some advantages over67Ga-citrate because of the higher concentration in the lesions.123I-transferrin reached a concentration in tumor similar to67Ga (6.89±1.67 vs 5.08±0.58% D/g) but had a very low tumor to blood ratio (0.64). The three compounds investigated (Ru-TF, I-TF and ionic Ga, which binds instantaneously to TF in vivo) have a common lignad, transferrin. It appears, therefore, that tumor affinity is a property of the radionuclide-ligand complex rather than of the radionuclide itself.

Original languageEnglish
Pages (from-to)491-494
Number of pages4
JournalEuropean Journal Of Nuclear Medicine
Volume8
Issue number11
DOIs
Publication statusPublished - 1983 Nov 1
Externally publishedYes

Fingerprint

Dive into the research topics of '97Ru-transferrin uptake in tumor and abscess'. Together they form a unique fingerprint.

Cite this